Filing Details

Accession Number:
0000899243-19-007113
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-03-11 19:18:12
Reporting Period:
2019-03-07
Accepted Time:
2019-03-11 19:18:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1631574 Wave Life Sciences Ltd. WVE Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1679039 A. Michael Panzara C/O Wave Life Sciences Ltd.,
733 Concord Ave.
Cambridge MA 02138
Franchise Lead, Neurology No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2019-03-07 15,000 $0.00 52,388 No 4 A Direct
Ordinary Shares Disposition 2019-03-11 7,000 $48.00 45,388 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Footnotes
  1. Consists of restricted share units (RSUs). The RSUs vest in four equal annual installments of 25% on February 15, 2020 through February 15, 2023.
  2. Consists of sale of RSUs effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2018.